CDK9-IN-44
CDK9-IN-44 (Compound 7) is a selective inhibitor of CDK9 with an IC50 of 7.6 μM. It effectively inhibits CDK9/cyclin T1 kinase activity, impedes transcription elongation, reduces the expression of oncogenic proteins such as MCL1 and c-MYC, and induces apoptosis in tumor cells. CDK9-IN-44 shows potential for research in glioblastoma (GBM) and central nervous system (CNS) diseases.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6310017-01 0.2 mL
IL1F6, ID (IL36A, FIL1E, IL1E, IL1F6, Interleukin-36 alpha, FIL1 epsilon, Interleukin-1 epsilon, Interleukin-1 family member 6) (FITC)
Sign In for Pricing
View Details